Company: PBH
Filing Date: 2025-05-09
Form Type: 10-K
Source: 0001295947-25-000017
Chunk: 131

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-05-09
Form: 10-K
Item: Item 8
Chunk 131
---
280.  Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare.  The primary measure used by our chief operating decision maker ("CODM") to evaluate the performance of our operating segments and allocate resources to these segments is contribution margin, which we define as gross profit less advertising and marketing expenses.  Information regarding total assets by operating segment is not provided to our CODM.  Our CODM is our Chief Executive Officer.  The tables below summarize information about our operating and reportable segments. Year Ended March 31, 2025(In thousands)North American OTCHealthcareInternational OTCHealthcareConsolidatedTotal segment revenues*$960,010 $177,752 $1,137,762 Cost of sales428,871 74,428 503,299 Gross profit531,139 103,324 634,463 Advertising and marketing129,431 26,292 155,723 Contribution margin$401,708 $77,032 478,740 Other operating expenses** 141,965 Operating income $336,775 *Intersegment revenues of $3.9 million were eliminated from the North American OTC Healthcare segment.**Other operating expenses for the year ended March 31, 2025 includes a tradename impairment charge of  $12.5 million. Year Ended March 31, 2024(In thousands)North American OTCHealthcareInternational OTCHealthcareConsolidatedTotal segment revenues*$958,260 $167,097 $1,125,357 Cost of sales429,361 71,548 500,909 Gross profit528,899 95,549 624,448 Advertising and marketing131,494 21,821 153,315 Contribution margin$397,405 $73,728 471,133 Other operating expenses128,704 Operating income$342,429 * Intersegment revenues of $3.7 million were eliminated from the North American OTC Healthcare segment.

76

 Year Ended March 31, 2023(In thousands)North American OTCHealthcareInternational OTCHealthcareConsolidatedTotal segment revenues* $973,774 $153,951 $1,127,725 Cost of sales441,844 60,587 502,431 Gross profit531,930 93,364 625,294